Special Survey for Type 1 or Type 2 Diabetic Patients

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Aspart

Criteria

Inclusion Criteria:

• Patients with diabetes requiring insulin therapy

Exclusion Criteria:

• Patients who had not been treated more than 3 months at the same investigational site

• Patients who had treatment history of NovoRapid® (insulin aspart)